The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Metastatic bulk to predict subclonal heterogeneity by ctDNA in RAS/RAF-wildtype colorectal cancer.
 
Jeremy D. Kratz
Travel, Accommodations, Expenses - Genentech
 
Sam Joseph Lubner
Stock and Other Ownership Interests - Elephas Bio
Consulting or Advisory Role - Elephas Bio
 
Noelle K. LoConte
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Celgene
 
Monica Arun Patel
Honoraria - OncLive/MJH Life Sciences
 
Nataliya Volodymyrivna Uboha
Stock and Other Ownership Interests - Exact Sciences (I); Natera (I)
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Gerson Lehrman Group; Guidepoint Global; Incyte; ipsen; LEK; Lilly; Lilly; M3; QED Therapeutics; Taiho Pharmaceutical; Taiho Pharmaceutical
Research Funding - EMD Serono (Inst); ipsen (Inst); Lilly (Inst); Taiho Pharmaceutical (Inst)
 
Dyan M. Lesnik
No Relationships to Disclose
 
Sara Ahmed
Employment - PierianDx
Leadership - PierianDx
Stock and Other Ownership Interests - PierianDx
 
Michael J. Kelley
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Novartis (Inst); Regeneron (Inst)
Other Relationship - IBM (Inst)
 
Kayla Lemmon
No Relationships to Disclose
 
Michael Frederick Bassetti
Research Funding - AstraZeneca; EMD Serono; Merck
 
Cristina Sanger
No Relationships to Disclose
 
Dustin A. Deming
Consulting or Advisory Role - Array BioPharma; Bayer; Lilly; Pfizer; Promega
Research Funding - Bayer; Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Millennium (Inst); Revolution Medicines (Inst)